Kathiresan Sekar

CIK 00018641123 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001864112

Recent Transactions

50 trades

Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-09-22+18,000→ 18,000 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−488,000→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−110,997→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−138,995→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−75,105→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−526,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−99,000→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−240,997→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−120,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−167,425→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−500,203→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−431,988→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−150,000→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−348,431→ 0 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2025-06-06+136,681→ 136,681 total
Sale
Verve Therapeutics, Inc.
Common Stock
2025-04-02$4.15/sh−9,822→ 346,686 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2025-04-01+33,000→ 356,508 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2025-04-01−33,000→ 99,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2025-01-08+120,000→ 120,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-01-08+150,000→ 150,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-01-08+488,000→ 488,000 total
Gift
Verve Therapeutics, Inc.
Common Stock
2024-12-04+30,000→ 110,997 total
Gift
Verve Therapeutics, Inc.
Common Stock
2024-12-04−30,000→ 323,508 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2024-06-28$2.87/sh+30,000→ 351,128 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-06-28−30,000→ 215,308 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2024-06-03+102,225→ 102,225 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-02-14+526,000→ 526,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2024-02-14+132,000→ 132,000 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2023-05-31+66,055→ 66,055 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-02-14+550,200→ 550,200 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-10-03−50,000→ 138,995 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-03$34.97/sh−9,904→ 317,839 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-10-03$1.39/sh+50,000→ 367,839 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-03$33.02/sh−28,911→ 338,928 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-10-03$34.13/sh−11,185→ 327,743 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-08-10$1.39/sh+50,000→ 367,839 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-08-10−50,000→ 167,425 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-08-10$29.90/sh−50,000→ 317,839 total
Award
Relay Therapeutics, Inc.$RLAY
Stock Option (Right to Buy)
2022-07-25+71,881→ 71,881 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-07-19$29.90/sh−50,000→ 317,839 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-19−50,000→ 217,425 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-07-19$1.39/sh+50,000→ 367,839 total
Gift
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-12−160,000→ 445,308 total
Gift
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-12+160,000→ 300,000 total
Gift
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-12+140,000→ 140,000 total
Gift
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-07-12−140,000→ 291,988 total
Gift
Verve Therapeutics, Inc.
Common Stock
2022-07-07+160,000→ 240,997 total
Gift
Verve Therapeutics, Inc.
Common Stock
2022-07-07−160,000→ 317,839 total
Exercise/Conversion
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-03-18−69,674→ 605,308 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-03-18$2.87/sh+69,674→ 477,525 total

Companies

Recent Filings

Address

C/O VERVE THERAPEUTICS, INC. 201 BROOKLINE AVENUE, SUITE 601

BOSTON, MA, 02215

View on SEC.gov